Sionna Therapeutics Inc (SION)

Currency in USD
21.48
+0.09(+0.42%)
Closed·
21.480.00(0.00%)
·
SION Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SION is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.6621.61
52 wk Range
7.2625.19
Key Statistics
Prev. Close
21.48
Open
21.46
Day's Range
20.66-21.61
52 wk Range
7.26-25.19
Volume
152.69K
Average Volume (3m)
186.54K
1-Year Change
-
Book Value / Share
7.63
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SION Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
38.50
Upside
+79.24%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

Sionna Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Sionna Therapeutics Inc Company Profile

Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; and SION-719 and SION-451, which are nucleotide-binding domain 1 stabilizers in Phase 1 trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.

Compare SION to Peers and Sector

Metrics to compare
SION
Peers
Sector
Relationship
P/E Ratio
−12.5x−3.0x−0.6x
PEG Ratio
-0.000.00
Price/Book
2.8x1.2x2.6x
Price / LTM Sales
-8.8x3.3x
Upside (Analyst Target)
81.9%211.1%40.1%
Fair Value Upside
Unlock5.1%5.3%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 38.50
(+79.24% Upside)

Earnings

Latest Release
Aug 11, 2025
EPS / Forecast
-0.41 / -0.52
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

SION Income Statement

People Also Watch

3.240
PRME
-7.43%
20.18
SRPT
-3.86%
2.050
VOR
+0.49%
2.40
INMB
-5.14%
3.62
ALT
+1.69%

FAQ

What Stock Exchange Does Sionna Therapeutics Trade On?

Sionna Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Sionna Therapeutics?

The stock symbol for Sionna Therapeutics is "SION."

What Is the Sionna Therapeutics Market Cap?

As of today, Sionna Therapeutics market cap is 918.99M.

What Is Sionna Therapeutics's Earnings Per Share (TTM)?

The Sionna Therapeutics EPS (TTM) is -3.79.

From a Technical Analysis Perspective, Is SION a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sionna Therapeutics Stock Split?

Sionna Therapeutics has split 0 times.

How Many Employees Does Sionna Therapeutics Have?

Sionna Therapeutics has 41 employees.

What is the current trading status of Sionna Therapeutics (SION)?

As of 20 Aug 2025, Sionna Therapeutics (SION) is trading at a price of 21.48, with a previous close of 21.48. The stock has fluctuated within a day range of 20.66 to 21.61, while its 52-week range spans from 7.26 to 25.19.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.